Back to search
FDAFDA · Food and drugs·Recall number D-0829-2021

Zonisamide 100 mg Capsules, 30-count bottles, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-0775-30

Published September 29, 2021 · Recall initiated: September 14, 2021

Summary

FDA records drug Class II recall D-0829-2021, published September 29, 2021 and initiated September 14, 2021. Recalling firm: Direct Rx; Status: Terminated; Reported quantity: 2 bottles; Lot: Lot #: 17JU2118 Exp. 5/31/23. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviations: Gaps in the quality system in the Quality Control microbiology laboratory.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Direct Rx
Distributor
FL only
Lot
Lot #: 17JU2118 Exp. 5/31/23
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zonisamide 100 mg Capsules, 30-count bottles, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-0775-30 recalled?

Yes. FDA published recall D-0829-2021 on September 29, 2021. Reported hazard: CGMP deviations: Gaps in the quality system in the Quality Control microbiology laboratory.

What should I do if I have this product?

Voluntary: Firm initiated · Letter